Stallion India Promoter Infuses ₹45.74 Crores for R-32 Project
Filing Summary
Stallion India Fluorochemicals Ltd announced on November 3, 2025, that its promoter has sold 16,20,987 shares, raising ₹45.74 crores. The funds will be infused into the company on an interest-free basis to support the development of the R-32 manufacturing facility in Bhilwara, Rajasthan. This initiative aims to ensure the timely commencement of the project’s groundwork and construction activities. The promoter’s action does not involve any equity dilution, maintaining the company’s capital structure. Stallion India specializes in refrigerants and industrial gases, serving diverse industries with tailored gas solutions.
On November 3, 2025, Stallion India Fluorochemicals Ltd (SIFL) disclosed that its promoter has sold 16,20,987 shares, generating ₹45.74 crores. The entire amount will be infused into the company on an interest-free basis. This capital will be directed towards the development of the company’s R-32 manufacturing facility located in Bhilwara, Rajasthan.
The funds are intended to facilitate the timely commencement of groundwork and construction activities for the R-32 project. The promoter’s decision to infuse funds without equity dilution reflects a commitment to maintaining the company’s existing capital structure. This action underscores the promoter’s confidence in the company’s strategic direction.
Mr. Shazad Rustomji, Managing Director & CEO of SIFL, confirmed the promoter’s decision to sell shares and infuse the proceeds into the company. The objective is to ensure that work on the R-32 project begins without delay. The promoter’s commitment is seen as a measure to advance the company’s vision of self-reliance in fluorochemicals manufacturing.
Stallion India Fluorochemicals Ltd, incorporated in 2002, is a specialized leader in the refrigerants and industrial gases sector. The company has established itself as a key player in processing, blending, and distributing gases across various industries, including air conditioning, refrigeration, fire-fighting, semiconductor manufacturing, pharmaceuticals, automotive, and glass production. SIFL operates four strategic manufacturing facilities focused on gas blending, differentiating it from competitors who primarily manufacture base molecules. The company consistently demonstrates a commitment to safety, innovation, and environmental responsibility.